Alternative Payment Models for Innovative Medicines: A Framework for Effective Implementation.

Area of Science:

• Health Economics
• Pharmaceutical Policy
• Value-Based Healthcare

Background:

• Scientific advancements present challenges in assessing value, affordability, and patient access to new medicines.
• Existing payer challenges require innovative solutions beyond traditional payment structures.
• A comprehensive framework for selecting and implementing alternative payment models (APMs) is currently lacking.

Purpose of the Study:

• To propose an evidence-based, step-by-step framework for the effective selection and implementation of APMs.
• To guide payers and manufacturers in aligning contracting challenges with appropriate APM solutions.
• To facilitate improved patient access to cost-effective medicines and incentivize future innovation.

Main Methods:

• Identification and mapping of contracting challenges to potential APM solutions using a decision guide.
• Categorization of main problems (budget impact, value uncertainty, scope of negotiation) and sub-categories (affordability, effectiveness uncertainty, patient heterogeneity).
• Assessment of solution feasibility, stakeholder collaboration, and analysis of implementation barriers using recent APM examples.

Main Results:

• A decision guide is developed to map core problems like budget impact and value uncertainty to APM solutions (e.g., outcome-based agreements, subscription models).
• The framework emphasizes feasibility assessment and collaboration for successful APM agreement and implementation.
• Real-world examples demonstrate overcoming common implementation barriers through pragmatic design and collaboration.

Conclusions:

• The proposed framework aids payers and manufacturers in effectively identifying, agreeing upon, and implementing APMs.
• Successful APM implementation can enhance patient access to cost-effective medicines.
• The framework supports appropriate incentives for continued pharmaceutical innovation.